COVID-19的分子路线图:从病毒入口到治疗点
Afeez Adekunle Ishola1, Idris Adewale Ahmed2,3, Maryam Abimbola Mikail2,3
1Developmental Therapeutics Branch (DTB) of the National Cancer Institute (NCI), National Institute of Health (NIH), Bethesda, Maryland, USA.
Chemistry & biodiversity
|October 30, 2025
概括
SARS-CoV-2 流行病需要通过了解其分子机制来开发新的治疗方法. 植物衍生化合物对抗COVID-19提供了有前途的抗病毒潜力.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 尽管SARS-CoV-2流行病的紧急阶段已经过去了,但仍需要有效的治疗方法来缓解死亡率和帮助恢复.
- 了解SARS-CoV-2准的宿主分子通路对于重新利用现有药物和开发新型抗病毒疗法至关重要.
- SARS-CoV-2 的高突变率强调了对抗病毒策略的持续研究和开发的需要.
研究的目的:
- 审查SARS-CoV-2感染的分子机制,包括病毒进入,复制和宿主信号通路.
- 确定针对SARS-CoV-2的药物发现的潜在治疗点.
- 讨论目前的趋势,临床管理和药物开发的未来前景,包括基于天然产品的干预措施.
主要方法:
- 包括PubMed,Science Direct,Scopus和谷歌学者在内的科学数据库的综合文献评论.
- 对SARS-CoV-2分子机制,感染趋势和临床特征的数据分析.
- 探索关于药物重新用途和新疗法开发的现有研究.
主要成果:
- 详细检查SARS-CoV-2的分子机制,宿主细胞向和复制策略.
- 确定关键的信号通路和潜在的治疗点进行干预.
- 强调植物化合物和草药的潜力,作为对抗COVID-19的有希望的抗病毒剂.
结论:
- 对SARS-CoV-2分子机制和宿主相互作用的持续研究对于有效的治疗开发至关重要.
- 为了应对SARS-CoV-2由于其高突变率而不断变化的威胁,多学科合作至关重要.
- 植物衍生化合物代表了开发新型抗病毒治疗COVID-19的可行和有前途的途径.
相关概念视频
01:29Microorganisms in Medicine and Therapeutics
908
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
908
01:26Targets for Drug Action: Overview
9.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.9K
02:28Leaky Scanning
5.6K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.6K
01:26Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
02:50Conjugated Proteins
27.0K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
27.0K
00:36Viral Mutations
39.5K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.5K